Apollo Hospitals Enterprise Ltd. - Research Center
508869 APOLLOHOSP Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Sep' 21 | Jun' 21 | Mar' 21 | Dec' 20 | Sep' 20 | |
|---|---|---|---|---|---|
| Sales | 2,823.20 | 2,994.71 | 2,410.07 | 2,367.01 | 2,414.45 |
| Operating profit | 438.86 | 390.59 | 335.83 | 321.92 | 248.22 |
| Interest | 64.39 | 63.76 | 68.27 | 75.77 | 97.15 |
| Gross profit | 382.76 | 335.57 | 278.30 | 247.08 | 155.86 |
| EPS (Rs) | 12.93 | 10.44 | 8.03 | 7.64 | 2.34 |
Quarterly
results in details
| Sep' 21 | Jun' 21 | Mar' 21 | Dec' 20 | Sep' 20 | |
|---|---|---|---|---|---|
| Other income | 8.29 | 8.74 | 10.74 | 0.93 | 4.79 |
| Stock adjustment | 78.93 | -125.13 | -1.15 | -7.62 | 14.59 |
| Raw material | 676.47 | 377.70 | 357.71 | 375.42 | 360.75 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 320.03 | 318.03 | 292.97 | 268.98 | 336.38 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1,308.91 | 2,033.52 | 1,424.71 | 1,408.31 | 1,454.51 |
| Provisions made | - | - | - | - | - |
| Depreciation | 93.73 | 96.00 | 101.40 | 91.78 | 116.33 |
| Taxation | 103.14 | 82.79 | 53.38 | 49.08 | 5.92 |
| Net profit / loss | 185.89 | 150.04 | 115.52 | 106.22 | 32.52 |
| Extra ordinary item | - | -6.74 | -8.00 | - | -1.09 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 71.89 | 71.89 | 71.89 | 69.56 | 69.56 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 15.54 | 13.04 | 13.93 | 13.60 | 10.28 |
| GPM (%) | 13.52 | 11.17 | 11.50 | 10.43 | 6.44 |
| NPM (%) | 6.57 | 5.00 | 4.77 | 4.49 | 1.34 |
Mutual Fund Selector
Find the fund that is right for you
© 2021 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis